A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors

Clinical trial NCT07376707 · RECRUITING

Trial details

NCT number: NCT07376707
Sponsor: Hefei TG ImmunoPharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CRC (Colorectal Cancer)Melanoma (Skin Cancer)HCC - Hepatocellular Carcinoma NSCLC (Non-small Cell Lung Cancer)

Start date: 2025-06-12
Primary completion: 2027-10-31
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.